Correlation Between Beta Drugs and SANOFI S

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Beta Drugs and SANOFI S at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Beta Drugs and SANOFI S into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Beta Drugs and SANOFI S HEALTHC, you can compare the effects of market volatilities on Beta Drugs and SANOFI S and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Beta Drugs with a short position of SANOFI S. Check out your portfolio center. Please also check ongoing floating volatility patterns of Beta Drugs and SANOFI S.

Diversification Opportunities for Beta Drugs and SANOFI S

-0.32
  Correlation Coefficient

Very good diversification

The 3 months correlation between Beta and SANOFI is -0.32. Overlapping area represents the amount of risk that can be diversified away by holding Beta Drugs and SANOFI S HEALTHC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SANOFI S HEALTHC and Beta Drugs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Beta Drugs are associated (or correlated) with SANOFI S. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SANOFI S HEALTHC has no effect on the direction of Beta Drugs i.e., Beta Drugs and SANOFI S go up and down completely randomly.

Pair Corralation between Beta Drugs and SANOFI S

Assuming the 90 days trading horizon Beta Drugs is expected to generate 2.03 times more return on investment than SANOFI S. However, Beta Drugs is 2.03 times more volatile than SANOFI S HEALTHC. It trades about 0.11 of its potential returns per unit of risk. SANOFI S HEALTHC is currently generating about -0.01 per unit of risk. If you would invest  175,770  in Beta Drugs on September 2, 2024 and sell it today you would earn a total of  41,415  from holding Beta Drugs or generate 23.56% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy87.3%
ValuesDaily Returns

Beta Drugs  vs.  SANOFI S HEALTHC

 Performance 
       Timeline  
Beta Drugs 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Beta Drugs are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady basic indicators, Beta Drugs unveiled solid returns over the last few months and may actually be approaching a breakup point.
SANOFI S HEALTHC 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days SANOFI S HEALTHC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, SANOFI S is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

Beta Drugs and SANOFI S Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Beta Drugs and SANOFI S

The main advantage of trading using opposite Beta Drugs and SANOFI S positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Beta Drugs position performs unexpectedly, SANOFI S can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SANOFI S will offset losses from the drop in SANOFI S's long position.
The idea behind Beta Drugs and SANOFI S HEALTHC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

Other Complementary Tools

USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules